Drug Type Small molecule drug |
Synonyms Glymacken, グリマッケン |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (01 Oct 1987), |
Regulation- |
Molecular FormulaC3H8O3 |
InChIKeyPEDCQBHIVMGVHV-UHFFFAOYSA-N |
CAS Registry56-81-5 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Intracranial Hypertension | Japan | 01 Oct 1987 | |
Ocular Hypertension | Japan | 01 Oct 1987 |